NYSE:NHI (USA)
Â
Ordinary Shares
$
67.61
-1.62 (-2.34%)
01:54 PM EST
Business Description
National Health Investors Inc
NAICS : 531120
SIC : 6798
ISIN : US63633D1046
Share Class Description:
NHI: Ordinary SharesTotal Employee Number:
32Description
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 4.09 | |||||
Interest Coverage | 3.52 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.18 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.7 | |||||
3-Year EBITDA Growth Rate | 13.7 | |||||
3-Year EPS without NRI Growth Rate | 16.5 | |||||
3-Year FCF Growth Rate | 6.7 | |||||
3-Year Book Growth Rate | 2.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.56 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.29 | |||||
9-Day RSI | 35.97 | |||||
14-Day RSI | 36.89 | |||||
3-1 Month Momentum % | 4.04 | |||||
6-1 Month Momentum % | -14.35 | |||||
12-1 Month Momentum % | -6.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.06 | |||||
Days Sales Outstanding | 74.01 | |||||
Days Payable | 1331.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.44 | |||||
Dividend Payout Ratio | 1.24 | |||||
3-Year Dividend Growth Rate | 0.4 | |||||
Forward Dividend Yield % | 5.57 | |||||
5-Year Yield-on-Cost % | 4.62 | |||||
3-Year Average Share Buyback Ratio | -3.6 | |||||
Shareholder Yield % | 1.12 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 97.52 | |||||
Operating Margin % | 45.4 | |||||
Net Margin % | 38.6 | |||||
EBITDA Margin % | 72.41 | |||||
FCF Margin % | 51.5 | |||||
OCF Margin % | 57.55 | |||||
ROE % | 11.02 | |||||
ROA % | 5.94 | |||||
ROIC % | 7.07 | |||||
3-Year ROIIC % | 21.74 | |||||
ROC (Joel Greenblatt) % | 1334.42 | |||||
ROCE % | 9.11 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-FFO | 13.95 | |||||
PE Ratio | 19.57 | |||||
Forward PE Ratio | 21.04 | |||||
PE Ratio without NRI | 19.67 | |||||
Shiller PE Ratio | 17.16 | |||||
Price-to-Owner-Earnings | 12.75 | |||||
PS Ratio | 7.57 | |||||
PB Ratio | 2.11 | |||||
Price-to-Tangible-Book | 2.11 | |||||
Price-to-Free-Cash-Flow | 13.06 | |||||
Price-to-Operating-Cash-Flow | 13.06 | |||||
EV-to-EBIT | 20.38 | |||||
EV-to-Forward-EBIT | 18.47 | |||||
EV-to-EBITDA | 14.37 | |||||
EV-to-Forward-EBITDA | 13.21 | |||||
EV-to-Revenue | 10.54 | |||||
EV-to-Forward-Revenue | 10.67 | |||||
EV-to-FCF | 20.46 | |||||
Price-to-GF-Value | 0.79 | |||||
Price-to-Projected-FCF | 0.98 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.32 | |||||
Price-to-Graham-Number | 1.46 | |||||
Earnings Yield (Greenblatt) % | 4.91 | |||||
FCF Yield % | 6.75 | |||||
Forward Rate of Return (Yacktman) % | 11.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:NHI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
National Health Investors Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 435.135 | ||
| EPS (TTM) ($) | 3.455 | ||
| Beta | 0.0736 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 0.7 | ||
| Volatility % | 17.92 | ||
| 14-Day RSI | 36.89 | ||
| 14-Day ATR ($) | 1.500584 | ||
| 20-Day SMA ($) | 71.4275 | ||
| 12-1 Month Momentum % | -6.2 | ||
| 52-Week Range ($) | 67.4401 - 91.38 | ||
| Shares Outstanding (Mil) | 49.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
National Health Investors Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
National Health Investors Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-26 10:00 | In 162 days | ||
| Annual report for 2026 | 2027-02-26 | In 161 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 161 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 10:00 | In 50 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 49 days | ||
| USD 0.940000 Cash Dividend | 2026-09-30 | In 12 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-11 08:30 | 74.15 (-1.40%) | ||
| Second quarter earnings results for 2026 | 2026-08-10 | 75.30 (+0.70%) | ||
| USD 0.920000 Cash Dividend | 2026-06-30 | 77.60 (+1.49%) | ||
| General meeting for 2026 | 2026-05-27 13:00 | 76.21 (-0.31%) |
Show
Entries
National Health Investors Inc Frequently Asked Questions
What is National Health Investors Inc(NHI)'s stock price today?
The current price of NHI is $67.61. The 52 week high of NHI is $91.38 and 52 week low is $67.44.
When is next earnings date of National Health Investors Inc(NHI)?
The next earnings date of National Health Investors Inc(NHI) is 2026-11-06 Est..
Does National Health Investors Inc(NHI) pay dividends? If so, how much?
The Dividend Yield %  of National Health Investors Inc(NHI) is 5.44% (As of Today), Highest Dividend Payout Ratio of National Health Investors Inc(NHI) was 1.89. The lowest was 1.01. And the median was 1.18. The  Forward Dividend Yield % of National Health Investors Inc(NHI) is 5.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers